Common Contracts
5 similar Executive Employment Agreement contracts by Spero Therapeutics, Inc.
EX-10.8 10 d431217dex108.htm EX-10.8 EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 5th, 2020 • Massachusetts
This Executive Employment Agreement (this “Agreement”) is made and entered into this 20th day of October, 2017 (the “Effective Date”) by and between Spero Therapeutics, Inc., a Delaware corporation (“Company”), and Cristina Larkin (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 23rd, 2017 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Executive Employment Agreement (this “Agreement”) is made and entered into this 20th day of October, 2017 (the “Effective Date”) by and between Spero Therapeutics, Inc., a Delaware corporation (“Company”), and Ankit Mahadevia (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 23rd, 2017 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Executive Employment Agreement (this “Agreement”) is made and entered into this 20th day of October, 2017 (the “Effective Date”) by and between Spero Therapeutics, Inc., a Delaware corporation (“Company”), and Joel Sendek (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 23rd, 2017 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Executive Employment Agreement (this “Agreement”) is made and entered into this 20th day of October, 2017 (the “Effective Date”) by and between Spero Therapeutics, Inc., a Delaware corporation (“Company”), and Cristina Larkin (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 23rd, 2017 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Executive Employment Agreement (this “Agreement”) is made and entered into this 20th day of October, 2017 (the “Effective Date”) by and between Spero Therapeutics, Inc., a Delaware corporation (“Company”), and Thomas Parr Jr. (“Executive”).
